INSULIN GLARGINE-YFGN: 1,802 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,802
Total FAERS Reports
3 (0.2%)
Deaths Reported
42
Hospitalizations
1,802
As Primary/Secondary Suspect
11
Life-Threatening
5
Disabilities
Prescription
Status
FDA Application: 761201 ·
First Report: 20220101 · Latest Report: 20250904
What Are the Most Common INSULIN GLARGINE-YFGN Side Effects?
#1 Most Reported
Device mechanical issue
853 reports (47.3%)
#2 Most Reported
Product quality issue
426 reports (23.6%)
#3 Most Reported
Device issue
279 reports (15.5%)
All INSULIN GLARGINE-YFGN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Device mechanical issue | 853 | 47.3% | 0 | 9 |
| Product quality issue | 426 | 23.6% | 1 | 1 |
| Device issue | 279 | 15.5% | 1 | 0 |
| Device delivery system issue | 236 | 13.1% | 0 | 2 |
| Device defective | 215 | 11.9% | 0 | 3 |
| Product storage error | 212 | 11.8% | 0 | 3 |
| Wrong technique in product usage process | 181 | 10.0% | 0 | 1 |
| Device breakage | 164 | 9.1% | 0 | 1 |
| Incorrect dose administered | 152 | 8.4% | 0 | 2 |
| Blood glucose increased | 115 | 6.4% | 0 | 7 |
| Product dose omission issue | 110 | 6.1% | 0 | 3 |
| Wrong technique in device usage process | 94 | 5.2% | 0 | 0 |
| Drug ineffective | 77 | 4.3% | 0 | 5 |
| Device leakage | 62 | 3.4% | 0 | 0 |
| Device malfunction | 60 | 3.3% | 0 | 0 |
| Needle issue | 58 | 3.2% | 0 | 0 |
| Weight increased | 56 | 3.1% | 0 | 0 |
| Weight decreased | 41 | 2.3% | 1 | 3 |
| Incorrect dose administered by device | 38 | 2.1% | 0 | 1 |
| Injection site atrophy | 27 | 1.5% | 0 | 0 |
Who Reports INSULIN GLARGINE-YFGN Side Effects? Age & Gender Data
Gender: 39.2% female, 60.8% male. Average age: 59.6 years. Most reports from: US. View detailed demographics →
Is INSULIN GLARGINE-YFGN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 128 | 0 | 0 |
| 2023 | 248 | 0 | 17 |
| 2024 | 73 | 1 | 5 |
| 2025 | 12 | 0 | 4 |
What Is INSULIN GLARGINE-YFGN Used For?
| Indication | Reports |
|---|---|
| Type 2 diabetes mellitus | 1,077 |
| Product used for unknown indication | 326 |
| Type 1 diabetes mellitus | 181 |
| Diabetes mellitus | 165 |
| Blood glucose abnormal | 5 |
INSULIN GLARGINE-YFGN vs Alternatives: Which Is Safer?
INSULIN GLARGINE-YFGN vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE-YFGN vs INSULIN GLULISINE
INSULIN GLARGINE-YFGN vs INSULIN HUMAN
INSULIN GLARGINE-YFGN vs INSULIN LISPRO
INSULIN GLARGINE-YFGN vs INSULIN LISPRO-AABC
INSULIN GLARGINE-YFGN vs INSULIN NOS
INSULIN GLARGINE-YFGN vs INSULIN PORK\INSULIN PURIFIED PORK
INSULIN GLARGINE-YFGN vs INTERFERON
INSULIN GLARGINE-YFGN vs INTERFERON ALFA-2A
INSULIN GLARGINE-YFGN vs INTERFERON ALFA-2A OR INTERFERON ALFA-2B
Official FDA Label for INSULIN GLARGINE-YFGN
Official prescribing information from the FDA-approved drug label.